Oramed Pharmaceuticals (ORMP) Interest Coverage Ratio Growth (5y) (2016 - 2021)
Oramed Pharmaceuticals (ORMP) Interest Coverage Ratio Growth (5y) (2016 - 2021) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2021 | -95.64% |
| Nov 30, 2019 | -7.03% |
| Aug 31, 2019 | 58.90% |
| May 31, 2019 | -42.73% |
| Feb 28, 2019 | 12.64% |
| Nov 30, 2018 | -1.84% |
| Aug 31, 2018 | 53.88% |
| May 31, 2018 | 6.00% |
| Feb 28, 2018 | -29.81% |
| Nov 30, 2017 | -121.39% |
| Aug 31, 2017 | -68.30% |
| May 31, 2017 | 30.27% |
| Feb 28, 2017 | -10.08% |
| Nov 30, 2016 | -24.24% |
| Aug 31, 2016 | 1.40% |
| May 31, 2016 | 18.17% |
| Feb 29, 2016 | 42.97% |